Numinus Wellness Inc. (NUMIF)

Market Cap	6.73M -40.0%
Revenue (ttm)	4.97M +3.6%
Net Income	5.07M
EPS	0.02
Shares Out	320.55M
PE Ratio	1.58
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	249,700
Open	0.0210
Previous Close	0.0220
Day's Range	0.0210 - 0.0210
52-Week Range	0.0055 - 0.0560
Beta	2.60
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 27, 2026

About Numinus Wellness

Numinus Wellness Inc. provides psychedelic-assisted therapy training, lab testing, and psychotherapy services in Canada and the United States. The company operates through Clinical Research Operations and Practitioner Training segments. It also provides clinical research management services to academic institutions and biotechnology companies. In addition, the company engages in the provision of education and training for research and drug development organizations to support clinical trials and commercialization efforts. The company serves bio...

• Industry: Medical Care Facilities
• Sector: Healthcare
• Founded: 1964
• Employees: 16
• Stock Exchange: OTCMKTS
• Ticker Symbol: NUMIF

Financial Performance

In fiscal year 2025, Numinus Wellness's revenue was 7.65 million, an increase of 78.25% compared to the previous year's 4.29 million. Losses were -3.44 million, -82.46% less than in 2024.

Financial numbers in CAD

Data Sources: S&P Global Market Intelligence and Twelve Data

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Twelve Data.

Last checked:

Sep 18, 2026

Data Sources Report a data error